Lymphatic Complications Following Sentinel Node Biopsy or Pelvic Lymphadenectomy for Endometrial Cancer
Authors:
- Shinichi TeradaSTShinichi Terada
- Tomohito TanakaTTTomohito Tanaka
- Hikaru MurakamiHikaru Murakami
- Hiromitsu TsuchihashiHTHiromitsu Tsuchihashi
- Akihiko TojiATAkihiko Toji
- Atsushi DaimonADAtsushi Daimon
- Shunsuke MiyamotoSMShunsuke Miyamoto
- Ruri NishieRNRuri Nishie
- Shoko UedaSUShoko Ueda
- Sousuke HashidaSHSousuke Hashida
- Natsuko MoritaNMNatsuko Morita
- Hiroshi MaruokaHMHiroshi Maruoka
Open Access
- 7 July 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (13) , 4540
Abstract
Sentinel node biopsy (SNB) is performed worldwide in patients with endometrial cancer (EC). The aim of this study was to evaluate and compare the occurrence rate of lymphatic complications between SNB and pelvic lymphadenectomy (LND) for EC. The medical records of women who underwent SNB or pelvic LND for EC between September 2012 and April 2022 were assessed. A total of 388 patients were enrolled in the current study. Among them, 201 patients underwent SNB and 187 patients underwent pelvic LND. The occurrence rates of lower-extremity lymphedema (LEL) and pelvic lymphocele (PL) were compared between the patients who underwent SNB and those who underwent pelvic LND. The SNB group had a significantly lower occurrence rate of lower-extremity LEL than the pelvic LND group (2.0% vs. 21.3%, p < 0.01). There were no patients who had PL in the SNB group; however, 4 (2.1%) patients in the pelvic LND group had PL. The occurrence rates of lower-extremity LEL and PL were significantly lower in patients who underwent SNB than those who underwent pelvic LND. SNB for EC has a lower risk of lymphatic complications compared to systemic LND.Keywords
This publication has 49 references indexed in Scilit:
- Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?Gynecologic Oncology, 2009
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2009
- Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epidemiology, and end results analysisInternational Journal of Gynecological Cancer, 2008
- The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patientsBritish Journal of Cancer, 2007
- Therapeutic role of lymph node resection in endometrioid corpus cancerCancer, 2006
- An Analysis of the Risk Factors and Management of Lymphocele after Pelvic Lymphadenectomy in Patients with Gynecologic MalignanciesCancer Research and Treatment, 2004
- Lymph Node Sampling and Survival in Endometrial CancerGynecologic Oncology, 1998
- Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node SamplingGynecologic Oncology, 1995
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group studyGynecologic Oncology, 1991